110 related articles for article (PubMed ID: 30665239)
1. Long-Term Treatment with Thrombomodulin Improves Functional Outcomes after Cerebral Ischemia Even if Administration is Delayed.
Nakano T; Nakamura Y; Matsuyama K; Irie K; Yasumura M; Hirata Y; Yamasaki M; Misumi K; Yamashita Y; Myose T; Matsuo K; Sano K; Kamimura H; Ishikura H; Egawa T; Mishima K
Thromb Haemost; 2019 Mar; 119(3):467-478. PubMed ID: 30665239
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice.
Nakamura Y; Nakano T; Irie K; Sano K; Tanaka J; Yamashita Y; Satho T; Matsuo K; Fujioka M; Ishikura H; Mishima K
J Neurol Sci; 2016 Mar; 362():278-82. PubMed ID: 26944163
[TBL] [Abstract][Full Text] [Related]
3. Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism.
Hayakawa K; Mishima K; Nozako M; Hazekawa M; Mishima S; Fujioka M; Orito K; Egashira N; Iwasaki K; Fujiwara M
Stroke; 2008 Mar; 39(3):951-8. PubMed ID: 18258837
[TBL] [Abstract][Full Text] [Related]
4. Haptoglobin Regulates Macrophage/Microglia-Induced Inflammation and Prevents Ischemic Brain Damage Via Binding to HMGB1.
Morimoto M; Nakano T; Egashira S; Irie K; Matsuyama K; Wada M; Nakamura Y; Shigemori Y; Ishikura H; Yamashita Y; Hayakawa K; Sano K; Mishima K
J Am Heart Assoc; 2022 Mar; 11(6):e024424. PubMed ID: 35243897
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human soluble thrombomodulin protects against brain injury in a CVST rat model, via downregulation of the HMGB1-RAGE axis.
Gu JJ; Chen JB; Zhang JH; Zhang H; Wang SS
Mol Med Rep; 2016 Dec; 14(6):5217-5222. PubMed ID: 27840921
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats.
Tanaka J; Seki Y; Ishikura H; Tsubota M; Sekiguchi F; Yamaguchi K; Murai A; Umemura T; Kawabata A
Br J Pharmacol; 2013 Nov; 170(6):1233-41. PubMed ID: 24004409
[TBL] [Abstract][Full Text] [Related]
7. Goreisan Prevents Brain Edema after Cerebral Ischemic Stroke by Inhibiting Aquaporin 4 Upregulation in Mice.
Nakano T; Nishigami C; Irie K; Shigemori Y; Sano K; Yamashita Y; Myose T; Tominaga K; Matsuo K; Nakamura Y; Ishikura H; Kamimura H; Egawa T; Mishima K
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):758-763. PubMed ID: 29153303
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants.
Mohri M; Sugimoto E; Sata M; Asano T
Thromb Haemost; 1999 Dec; 82(6):1687-93. PubMed ID: 10613656
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism.
Hayakawa K; Mishima K; Irie K; Hazekawa M; Mishima S; Fujioka M; Orito K; Egashira N; Katsurabayashi S; Takasaki K; Iwasaki K; Fujiwara M
Neuropharmacology; 2008 Dec; 55(8):1280-6. PubMed ID: 18634812
[TBL] [Abstract][Full Text] [Related]
10. Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis.
Tanaka J; Yamaguchi K; Ishikura H; Tsubota M; Sekiguchi F; Seki Y; Tsujiuchi T; Murai A; Umemura T; Kawabata A
Neuropharmacology; 2014 Apr; 79():112-8. PubMed ID: 24262631
[TBL] [Abstract][Full Text] [Related]
11. Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain.
Kim JB; Lim CM; Yu YM; Lee JK
J Neurosci Res; 2008 Apr; 86(5):1125-31. PubMed ID: 17975839
[TBL] [Abstract][Full Text] [Related]
12. Enhanced effect of recombinant human soluble thrombomodulin by ultrasound irradiation in acute liver failure.
Hoshino K; Nakamura Y; Nakano T; Watanabe A; Sheng H; Tachibana K; Ishikura H
Sci Rep; 2020 Feb; 10(1):1742. PubMed ID: 32015385
[TBL] [Abstract][Full Text] [Related]
13. Alarmin HMGB1 induces systemic and brain inflammatory exacerbation in post-stroke infection rat model.
Kim ID; Lee H; Kim SW; Lee HK; Choi J; Han PL; Lee JK
Cell Death Dis; 2018 Apr; 9(4):426. PubMed ID: 29555931
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window.
Yu YM; Kim JB; Lee KW; Kim SY; Han PL; Lee JK
Stroke; 2005 Oct; 36(10):2238-43. PubMed ID: 16141417
[TBL] [Abstract][Full Text] [Related]
15. Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain.
Shin JH; Lee HK; Lee HB; Jin Y; Lee JK
Neurosci Lett; 2014 Jan; 558():159-63. PubMed ID: 24246904
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin Pretreatment Attenuates Ischemic Brain Edema by Suppressing Aquaporin 4.
Cheng ZJ; Dai TM; Shen YY; He JL; Li J; Tu JL
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3247-3255. PubMed ID: 30093197
[TBL] [Abstract][Full Text] [Related]
17. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
[TBL] [Abstract][Full Text] [Related]
18. The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis).
Mohri M; Gonda Y; Oka M; Aoki Y; Gomi K; Kiyota T; Sugihara T; Yamamoto S; Ishida T; Maruyama I
Blood Coagul Fibrinolysis; 1997 Jul; 8(5):274-83. PubMed ID: 9282791
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
[TBL] [Abstract][Full Text] [Related]
20. Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model.
Iba T; Nakarai E; Takayama T; Nakajima K; Sasaoka T; Ohno Y
Crit Care; 2009; 13(6):R203. PubMed ID: 20003418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
